CLINICAL_TRIALS
trial_result
· 2017-02-02
Clinical Trial Update: Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy
Summary
A completed CAPRISA study examines tuberculosis recurrence in people receiving highly active antiretroviral therapy (ART) for HIV in South Africa.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre for the AIDS Programme of Research in South Africa | Conditions: Tuberculosis | Status: COMPLETED